Pursuing Later Treatment Option II (PLATO II) project team and Observational HIV Epidemiological Research Europe (COHERE) Group, “Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study,” Lancet Infectious Diseases, vol. 12, no. 2, pp. 119–127, 2012.
[2]
F. Nakagawa, R. K. Lodwick, C. J. Smith et al., “Projected life expectancy of people with HIV according to timing of diagnosis,” AIDS, vol. 26, no. 3, pp. 335–343, 2012.
[3]
F. Boccara, “Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors,” AIDS, vol. 22, supplement 3, pp. S19–S26, 2008.
[4]
S. Franceschi, M. Lise, G. M. Clifford, et al., “Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study,” British Journal of Cancer, vol. 103, no. 3, pp. 416–422, 2010.
[5]
V. W. Harris and T. T. Brown, “Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies,” Journal of Infectious Diseases, vol. 205, supplement 3, pp. S391–S398, 2012.
[6]
H. Kovari, C. A. Sabin, B. Ledergerber, et al., “Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of HBV or HCV co-infection. The data collection on adverse events of anti-HIV drugs (D:A:D) study,” Clinical Infectious Diseases. In press.
[7]
The Mind Exchange Working Group, “Assessment, diagnosis and treatment of human immunodeficiency virus (HIV)-associated neurocognitive disorders (HAND): a consensus report of the mind exchange program,” Clinical Infectious Diseases. In press.
[8]
R. Sullivan, J. Peppercorn, K. Sikora, et al., “Delivering affordable cancer care in high-income countries,” The Lancet Oncology, vol. 12, no. 10, pp. 933–980, 2011.
[9]
R. Khammassia, L. Pantanowitz, and L. Feller, “Oral HIV-associated Kaposis sarcoma: a clinical study from the Ga-Rankuwa area, South Africa,” AIDS Research and Treatment, vol. 2012, Article ID 873181, 9 pages, 2012.
[10]
R. Khammassia, L. Feller, M. Altini, P. Fatti, and J. Lemmer, “A comparison of chronic periodontitis in HIV-seropositive subjects and the general population in the Ga-Rankuwa area, South Africa,” AIDS Research and Treatment, vol. 2012, Article ID 620962, 7 pages, 2012.
[11]
E. Marseille, J. G. Kahn, F. Mmiro et al., “Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa,” The Lancet, vol. 354, no. 9181, pp. 803–809, 1999.
[12]
F. Nakagawa, R. K. Lodwick, C. J. Smith et al., “Projected life expectancy of people with HIV according to timing of diagnosis,” AIDS, vol. 26, no. 3, pp. 335–343, 2012.
